Research

The German Research Foundation (DFG) is funding a new research training group at FAU that is investigating modern functional materials and thus making a major contribution to their efficient use in sustainable technologies such as photovoltaics, batteries and hydrogen.

In future, the production of bioactive molecules and drugs could do without external enzyme or metal catalysts. Chemists at FAU have developed a process in which an organoautocatalyst formed in situ enables the chemical synthesis of bioactive cyclic amine compounds with high efficiency under mild conditions.

Artificial intelligence (AI) algorithms are increasingly being used in medical diagnostics. But in many areas, their potential is still barely being exploited. A cooperation project between FAU's UKER and Gravina Hospital in Caltagirone (Italy) demonstrates that there is another way.

Researchers at FAU and the University Hospital Erlangen have succeeded in treating a patient with a particularly severe form of autoimmune disease with two different types of CAR T cells in succession. The results have now been published in the renowned journal Nature Medicine.

DFG funding for semiconductor development and bowel cancer research Major success for FAU: The German Research Foundation (DFG) has awarded funding for two new collaborative research centers at Friedrich-Alexander-Universität Erlangen-Nürnberg – one in semiconductor research and the second in cance...

Symmetry is a basic characteristic of most multicellular animals. However, asymmetry prevails in the cell division of embryonic cells. An FAU team has developed a working model that explains the molecular mechanism by which the protein anillin controls the asymmetry in the constriction of the mother cell.

Islamic sermons are often seen as a source of radicalization. The "Interactions" project, based at the Research Center for Islam and Law in Europe at FAU, has investigated the extent to which radical content is preached in German mosques.

Using an electron microscope, a research team from FAU and the UKER was able to visualize an important risk factor for the diseases: the structure of the enzyme GCase in conjunction with its transport protein LIMP-2, which transports the enzyme through the cell to its site of action.

Bioinformaticians from FAU and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have developed a new tool. It can be used to better evaluate the performance of AI models. The researchers have presented their approach in "Nature Communications".

Great joy at FAU: The "Transforming Human Rights" research project becomes a Cluster of Excellence. The FAU application convinced the Excellence Commission with its plan to shed light on human rights challenges against the backdrop of global megatrends and to investigate the transformation of human rights norms, institutions and practices.